<VariationArchive VariationID="15879" VariationName="NM_000558.5(HBA1):c.283_300+3dup" VariationType="Duplication" Accession="VCV000015879" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-28" DateCreated="2013-04-04" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="981947" VariationID="15879">
      <GeneList>
        <Gene Symbol="HBA1" FullName="hemoglobin subunit alpha 1" GeneID="3039" HGNC_ID="HGNC:4823" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="176680" stop="177522" display_start="176680" display_stop="177522" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="226678" stop="227519" display_start="226678" display_stop="227519" Strand="+" />
          </Location>
          <OMIM>141800</OMIM>
        </Gene>
        <Gene Symbol="LOC106804613" FullName="hemoglobin subunit alpha 1 recombination region" GeneID="106804613" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="174618" stop="177541" display_start="174618" display_stop="177541" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000558.5(HBA1):c.283_300+3dup</Name>
      <CanonicalSPDI>NC_000016.10:177111:GGTGGACCCGGTCAACTTCAAGGTG:GGTGGACCCGGTCAACTTCAAGGTGGACCCGGTCAACTTCAAGGTG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="177111" stop="177112" display_start="177111" display_stop="177112" variantLength="21" positionVCF="177111" referenceAlleleVCF="G" alternateAlleleVCF="GGGTGGACCCGGTCAACTTCAA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="227110" stop="227111" display_start="227110" display_stop="227111" variantLength="21" positionVCF="227110" referenceAlleleVCF="G" alternateAlleleVCF="GGGTGGACCCGGTCAACTTCAA" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_046166.1" sequenceAccession="NG_046166" sequenceVersion="1" change="g.2599_2619dup">
            <Expression>NG_046166.1:g.2599_2619dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_059186.1" sequenceAccession="NG_059186" sequenceVersion="1" change="g.5466_5486dup">
            <Expression>NG_059186.1:g.5466_5486dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000558.5" sequenceAccession="NM_000558" sequenceVersion="5" change="c.283_300+3dup" MANESelect="true">
            <Expression>NM_000558.5:c.283_300+3dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.177116_177136dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.177116_177136dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.227115_227135dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.227115_227135dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_000006.1" sequenceAccession="NG_000006" sequenceVersion="1" change="g.37979_37999dup">
            <Expression>NG_000006.1:g.37979_37999dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000558.5" sequenceAccession="NM_000558" sequenceVersion="5" change="c.280_300dup" MANESelect="true">
            <Expression>NM_000558.5:c.280_300dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1225" sequenceAccession="LRG_1225">
            <Expression>LRG_1225:g.5466_5486dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1225t1" sequenceAccession="LRG_1225t1">
            <Expression>LRG_1225t1:c.283_300+3dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="141800.0206" DB="OMIM" />
        <XRef Type="rs" ID="1902161681" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000558.5(HBA1):c.283_300+3dup AND Alpha-thalassemia, Dutch type" Accession="RCV000017225" Version="27">
        <ClassifiedConditionList TraitSetID="4909">
          <ClassifiedCondition DB="MedGen" ID="C1456873">Alpha-thalassemia, Dutch type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000558.5(HBA1):c.283_300+3dup AND not provided" Accession="RCV003736542" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-04" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11791872</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="4909" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="12181" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alpha plus thalassemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Alpha-thalassemia, Dutch type</ElementValue>
              </Name>
              <XRef ID="C1456873" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="37497" SubmissionDate="2016-07-20" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="141800.0206_THALASSEMIA, ALPHA-PLUS" title="HBA1, 21-BP INS-DUP_THALASSEMIA, ALPHA-PLUS" />
        <ClinVarAccession Accession="SCV000037497" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient of Iranian descent with the hematologic profile of alpha-plus-thalassemia characterized by mild microcytosis, Waye et al. (2001) found a 21-bp insertion/duplication that gave rise to a predicted alpha-globin chain containing a duplication of amino acid residues 93-99.</Attribute>
              <Citation>
                <ID Source="PubMed">11791872</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBA1" />
          </GeneList>
          <Name>HBA1, 21-BP INS-DUP</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">21-BP INS-DUP</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="141800.0206" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">THALASSEMIA, ALPHA-PLUS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8351887" SubmissionDate="2024-01-24" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="2369781|MedGen:CN235283" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004563159" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" OrgAbbreviation="ARUP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The Hb SKMC (HBA1: c.283_300+3dup; p.?, rs1902161681, HbVar ID: 2952) variant is reported in the literature in the heterozygous state in individuals with alpha-thalassemia trait, and in the homozygous or compound heterozygous state in individuals with severe anemia and Hb H disease (Farashi 2015, Wajcman 2008, Waye 2001, see link to HbVar). This variant duplicates 21 nucleotides at the end of exon 2, which is predicted to result in a duplication of seven amino acid residues, but computational analyses (Alamut v.2.11) predict that this variant may also impact splicing by shifting the canonical donor splice site. Functional analyses do not detect an abnormal protein, suggesting that the Hb SKMC variant creates an unstable hemoglobin (Waye 2001). This variant is also absent from the Genome Aggregation Database, indicating it is not a common polymorphism. Based on available information, this variant is considered to be pathogenic. References: Link to HbVar database: https://globin.bx.psu.edu/hbvar/menu.html Farashi S et al. A 21 Nucleotide Duplication on the alpha1- and alpha2-Globin Genes Involves a Variety of Hypochromic Microcytic Anemias, From Mild to Hb H Disease. Hemoglobin. 2015;39(3):196-200. PMID: 25976776. Wajcman H et al. Unstable and thalassemic alpha chain hemoglobin variants: a cause of Hb H disease and thalassemia intermedia. Hemoglobin. 2008;32(4):327-49. PMID: 18654884. Waye JS et al. Identification of two new alpha-thalassemia mutations in exon 2 of the alpha1-globin gene. Hemoglobin. 2001 Nov;25(4):391-6. PMID: 11791872.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2024</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/xwiqgyug/arup_molecular_germline_variant_investigation_process_arup-info-0022_2024.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.227115_227135dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN235283" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023 ARUP ClinVar submission</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="37497" TraitType="Disease" MappingType="Name" MappingValue="THALASSEMIA, ALPHA-PLUS" MappingRef="Preferred">
        <MedGen CUI="C1456873" Name="Alpha-thalassemia, Dutch type" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8351887" TraitType="Disease" MappingType="XRef" MappingValue="CN235283" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

